Showing results (131-140 of 205) with videos related to

Sort By:
Pageof 21
HIV Medicine|January 28, 2026
Exploring the impact of Cabotegravir-Rilpivirine long-acting on weight gain, body composition and quality of life in adults living with HIVAndrea De Vito, Andrea Marongiu, Antonella Cano, et al.
Journal of Infection in Developing Countries|April 11, 2021
The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patientsAngelo Zinellu, Andrea De Vito, Valentina Scano, et al.
Panminerva Medica|May 27, 2022
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patientsAndrea DE Vito, Laura Saderi, Vito Fiore, et al.
International Journal of Environmental Research and Public Health|March 4, 2020
Long-Term Subjective Outcomes of Barbed Reposition Pharyngoplasty for Obstructive Sleep Apnea Syndrome TreatmentGiannicola Iannella, Bianca Vallicelli, Giuseppe Magliulo, et al.
Journal of Medical Virology|October 8, 2023
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort studyFilippo Lagi, Andrea Giacomelli, Vanni Borghi, et al.
International Forum of Allergy & Rhinology|March 14, 2022
Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variantPaolo Boscolo-Rizzo, Giancarlo Tirelli, Pierluigi Meloni, et al.
The Laryngoscope|November 23, 2021
New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID-19 After Complete VaccinationLuigi A Vaira, Andrea De Vito, Jerome R Lechien, et al.
AIDS Research and Human Retroviruses|December 31, 2021
Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral RegimenLaura Magnasco, Rachele Pincino, Giuseppe Pasculli, et al.
Journal of Global Antimicrobial Resistance|January 30, 2025
Assessing the utilization of HIV genotype resistance testing: Insight from Italian Infectious Diseases UnitsAndrea De Vito, Antonia Bezenchek, Rossana Scutari, et al.
American Journal of Otolaryngology|June 24, 2023
Recovery from olfactory and gustatory dysfunction following COVID-19 acquired during Omicron BA.1 wave in ItalyPaolo Boscolo-Rizzo, Giancarlo Tirelli, Pierluigi Meloni, et al.
Pageof 21